Alignment Healthcare (NASDAQ:ALHC) Price Target Cut to $12.00 by Analysts at TD Cowen

Alignment Healthcare (NASDAQ:ALHC) had its target price decreased by TD Cowen from $21.00 to $12.00 in a report issued on Monday morning,Benzinga reports. TD Cowen currently has a buy rating on the stock.

Several other equities research analysts have also commented on the stock. Wall Street Zen lowered shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Scotiabank set a $9.00 price objective on shares of Alignment Healthcare in a research note on Friday. KeyCorp dropped their price objective on shares of Alignment Healthcare from $28.00 to $12.00 and set an “overweight” rating on the stock in a report on Friday. Zacks Research lowered shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 6th. Finally, Weiss Ratings cut shares of Alignment Healthcare from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday. Seven investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $16.82.

Alignment Healthcare Stock Performance

Shares of ALHC opened at $8.09 on Monday. The firm has a market capitalization of $1.68 billion, a P/E ratio of 42.58 and a beta of 1.14. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70. Alignment Healthcare has a one year low of $6.01 and a one year high of $25.12. The business has a fifty day moving average of $11.36 and a 200 day moving average of $16.56.

Alignment Healthcare (NASDAQ:ALHC) last posted its earnings results on Thursday, July 30th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.13 by $0.04. The company had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.31 billion. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%. Alignment Healthcare’s revenue was up 31.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.07 earnings per share. As a group, sell-side analysts anticipate that Alignment Healthcare will post 0.15 EPS for the current year.

Insider Activity

In other news, President Dawn Maroney sold 122,707 shares of the stock in a transaction on Friday, September 11th. The shares were sold at an average price of $12.68, for a total value of $1,555,924.76. Following the completion of the sale, the president directly owned 794,606 shares of the company’s stock, valued at $10,075,604.08. This represents a 13.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Hyong Kim sold 32,479 shares of the stock in a transaction on Tuesday, October 6th. The stock was sold at an average price of $8.30, for a total value of $269,575.70. Following the completion of the sale, the insider owned 299,271 shares of the company’s stock, valued at $2,483,949.30. The trade was a 9.79% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 1,061,967 shares of company stock worth $13,642,490 in the last quarter. 5.20% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Versant Capital Management Inc grew its holdings in Alignment Healthcare by 463.3% during the 2nd quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock valued at $33,000 after buying an additional 1,135 shares in the last quarter. Nykredit A S purchased a new position in shares of Alignment Healthcare in the second quarter worth $36,000. Signature Equity Partners LLC purchased a new position in shares of Alignment Healthcare in the first quarter worth $46,000. GAMMA Investing LLC lifted its holdings in shares of Alignment Healthcare by 46.6% in the second quarter. GAMMA Investing LLC now owns 3,368 shares of the company’s stock worth $80,000 after buying an additional 1,070 shares in the last quarter. Finally, Fifth Third Bancorp purchased a new position in shares of Alignment Healthcare in the first quarter worth $122,000. 86.19% of the stock is currently owned by institutional investors.

Trending Headlines about Alignment Healthcare

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Alignment Healthcare is bouncing back after the previous session’s steep decline, suggesting some investors are viewing the selloff as an opportunity to buy the dip. Alignment Healthcare bounces back after sharp prior-session drop
• Positive Sentiment: The company launched a new Medicare Advantage plan designed for Asian American seniors in Los Angeles and Orange counties. The targeted product expands ALHC’s local-market reach and could support membership growth, although the financial impact will depend on enrollment and execution. Alignment Health launches new Medicare Advantage plan
• Neutral Sentiment: TD Cowen reduced its price target from $21 to $12 but maintained a “Buy” rating. The lower target reflects more cautious expectations, while the retained rating indicates the firm still sees substantial long-term upside from the stock’s recent levels.
• Neutral Sentiment: Recent coverage also compares Alignment Healthcare with Castle Biosciences and reviews institutional views of ALHC. These articles provide investment context but do not identify a new company-specific operating catalyst. Critical contrast between Alignment Healthcare and Castle Biosciences What investment firms are thinking about Alignment Healthcare
• Negative Sentiment: JPMorgan issued a pessimistic forecast for ALHC, adding to pressure on the shares and reinforcing concerns about the company’s near-term outlook. JPMorgan pessimistic forecast for Alignment Healthcare
• Negative Sentiment: KeyCorp cut its price target, and the stock subsequently reached a new 12-month low following analyst downgrading activity. These revisions likely contributed to the earlier selloff and remain an overhang despite the rebound. Alignment Healthcare stock price target cut by KeyCorp Alignment Healthcare hits new 12-month low

About Alignment Healthcare

Alignment Healthcare, Inc is a technology-enabled Medicare Advantage company focused on providing health coverage and care services for older adults. The company offers Medicare Advantage plans that combine medical benefits with care coordination, wellness support, and other services designed to help members manage their health.

Alignment operates through an integrated healthcare model that uses its proprietary technology platform to support physicians, care teams, and members. Its services include personalized care management, clinical coordination, virtual and in-home support, and member assistance through its concierge-style approach.